Berberine inhibits the LPS-induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling pathway

Experimental and Therapeutic Medicine

Volumn 14, Issue 6, 2017, Pages 6125-6130

  Liu, Li ^a   Chen, Li ^a   Jiang, Caixia ^a   Guo, Jing ^a   Xie, Yan ^a   Kang, Le ^a   Cheng, Zhongping ^a  

^a Tongji University School of Medicine   (China)

Author keywords

Adenomyosis; Berberine; Lipopolysaccharide; Proliferation; Stromalcells

Indexed keywords

BERBERINE; FLUORESCEIN ISOTHIOCYANATE; GELATINASE A; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; TOLL LIKE RECEPTOR 4;

ADENOMYOSIS; ADULT; APOPTOSIS; ARTICLE; BIOPSY; CASE REPORT; CELL COUNTING; CELL CYCLE ASSAY; CELL INVASION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LAPAROSCOPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; WESTERN BLOTTING;

EID: 85032587172     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2017.5316     Document Type: Article

References (41)

1. Harvey J and Warwick I: Endometriosis. BMJ 340: c2661, 2010.
2. Korzekwa A, Łupicka M, Socha B, Mannelli Ch and Skarzynski DJ: Is adenomyosis a problem in reproduction and fertility? Pol J Vet Sci 17: 187-194, 2014.
3. Farquhar C and Brosens I: Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol 20: 603-616, 2006.
4. Lousse JC, Van Langendonckt A, Defrere S, Ramos RG, Colette S and Donnez J: Peritoneal endometriosis is an inflammatory disease. Front Biosci (Elite Ed) 4: 23-40, 2012.
5. Sheldon IM and Bromfield JJ: Innate immunity in the human endometrium and ovary. Am J Reprod Immunol 66 (Suppl 1): S63-S71, 2011.
6. Bertschi D, McKinnon BD, Evers J, Bersinger NA and Mueller MD: Enhanced inflammatory activity of endometriotic lesions from the rectovaginal septum. Mediators Inflamm 2013: 450950, 2013.
7. Guo J, Chen L, Luo N, Li C, Chen R, Qu X, Liu M, Kang L and Cheng Z: LPS/TLR4-mediated stromal cells acquire an invasive phenotype and are implicated in the pathogenesis of adenomyosis. Sci Rep 6: 21416, 2016.
8. Pan L, Wang W, Shi F, Zhou J, Zhang M, Zhu H and Zeng M: Exploratory pharmacokinetics of Geniposide in rat model of cerebral ischemia orally administered with or without Baicalin and/or Berberine. Evid Based Complement Alternat Med 2013: 349531, 2013.
9. Sun Y, Xun K, Wang Y and Chen X: A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 20: 757-769, 2009.
10. Kong WJ, Zhang H, Song DQ, Xue R, Zhao W, Wei J, Wang YM, Shan N, Zhou ZX, Yang P, et al: Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism 58: 109-119, 2009.
11. Singh IP and Mahajan S: Berberine and its derivatives: A patent review (2009-2012). Expert Opin Ther Pat 23: 215-231, 2013.
12. Yin J, Zhang H and Ye J: Traditional chinese medicine in treatment of metabolic syndrome. Endoc Metab Immune Disord Drug Targets 8: 99-111, 2008.
13. Jin P, Zhang C and Li N: Berberine exhibits antitumor effects in human ovarian cancer cells. Anticancer Agents Med Chem 15: 511-516, 2015.
14. Li J, Cao B, Liu X, Fu X, Xiong Z, Chen L, Sartor O, Dong Y and Zhang H: Berberine suppresses androgen receptor signaling in prostate cancer. Mol Cancer Ther 10: 1346-1356, 2011.
15. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, et al: Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55: 2256-2264, 2006.
16. Chen Q, Qin R, Fang Y and Li H: Berberine sensitizes human ovarian cancer cells to cisplatin through miR-93/PTEN/Akt signaling pathway. Cell Physiol Biochem 36: 956-965, 2015.
17. Marverti G, Ligabue A, Lombardi P, Ferrari S, Monti MG, Frassineti C and Costi MP: Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells. Int J Oncol 43: 1269-1280, 2013.
18. Exacoustos C, Manganaro L and Zupi E: Imaging for the evaluation of endometriosis and adenomyosis. Best Pract Res Clin Obst Gynaecol 28: 655-681, 2014.
19. Rajaei S, Mirahmadian M, Jeddi-Tehrani M, Tavakoli M, Zonoobi M, Dabbagh A and Zarnani AH: Effect of 1,25(OH)2 vitamin D3 on cytokine production by endometrial cells of women with repeated implantation failure. Gynecol Endocrinol 28: 906-911, 2012.
20. Wan L, Zou Y, Wan LH, Wang LQ, Huang MZ, Wu J, Zhu YB and Huang OP: Tanshinone IIA inhibits the proliferation, migration and invasion of ectopic endometrial stromal cells of adenomyosis via 14-3-3zeta downregulation. Arch Gynecol Obstet 292: 1301-1309, 2015.
21. Yang JH, Wu MY, Chen CD, Chen MJ, Yang YS and Ho HN: Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis. Hum Reprod 22: 945-952, 2007.
22. Bruse C, Guan Y, Carlberg M, Carlström K and Bergqvist A: Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells. Fertil Steril 83 (Suppl 1): S1155-S1160, 2005.
23. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
24. Miller SI, Ernst RK and Bader MW: LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3: 36-46, 2005.
25. Lu YC, Yeh WC and Ohashi PS: LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151, 2008.
26. Azuma Y, Taniguchi F, Nakamura K, Nagira K, Khine YM, Kiyama T, Uegaki T, Izawa M and Harada T: Lipopolysaccharide promotes the development of murine endometriosis-like lesions via the nuclear factor-kappa B pathway. Am J Reprode Immunol 77, 2017.
27. Allhorn S, Böing C, Koch AA, Kimmig R and Gashaw I: TLR3 and TLR4 expression in healthy and diseased human endometrium. Reprod Biol Endocrinol 6: 40, 2008.
28. Chu M, Ding R, Chu ZY, Zhang MB, Liu XY, Xie SH, Zhai YJ and Wang YD: Role of berberine in anti-bacterial as a high-affinity LPS antagonist binding to TLR4/MD-2 receptor. BMC Complement Alternat Med 14: 89, 2014.
29. Huang LH, Pan XP, Gong KR and Shao G: Anti-inflammatory effects of three kinds of traditional Mongolian medicine monomer and its combination on LPS-stimulated RAW264.7 macrophages. Eur Rev Med Pharmacol Sci 20: 950-958, 2016.
30. Li HM, Wang YY, Wang HD, Cao WJ, Yu XH, Lu DX, Qi RB, Hu CF and Yan YX: Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms. Acta Pharmacol Sin 32: 1364-1372, 2011.
31. Benagiano G, Brosens I and Habiba M: Structural and molecular features of the endomyometrium in endometriosis and adenomyosis. Hum Reprod Update 20: 386-402, 2014.
32. Yang JH, Chen MJ, Wu MY, Chen YC, Yang YS and Ho HN: Decreased suppression of interleukin-6 after treatment with medroxyprogesterone acetate and danazol in endometrial stromal cells of women with adenomyosis. Fertil Steril 86: 1459-1465, 2006.
33. May KE, Conduit-Hulbert SA, Villar J, Kirtley S, Kennedy SH and Becker CM: Peripheral biomarkers of endometriosis: A systematic review. Hum Reprod Update 16: 651-674, 2010.
34. Younis A, Hawkins K, Mahini H, Butler W and Garelnabi M: Serum tumor necrosis factor-α, interleukin-6, monocyte chemo-tactic protein-1 and paraoxonase-1 profiles in women with endometriosis, PCOS, or unexplained infertility. J Assist Reprod Genet 31: 1445-1451, 2014.
35. Khan KN, Masuzaki H, Fujishita A, Kitajima M, Hiraki K, Sekine I, Matsuyama T and Ishimaru T: Interleukin-6- and tumour necrosis factor alpha-mediated expression of hepatocyte growth factor by stromal cells and its involvement in the growth of endometriosis. Hum Reprod 20: 2715-2723, 2005.
36. Sotnikova N, Antsiferova I and Malyshkina A: Cytokine network of eutopic and ectopic endometrium in women with adenomyosis. Am J Reprod Immunol 47: 251-255, 2002.
37. Omwandho CO, Konrad L, Halis G, Oehmke F and Tinneberg HR: Role of TGF-betas in normal human endometrium and endometriosis. Hum Reprod 25: 101-109, 2010.
38. Kang S, Zhao J, Liu Q, Zhou R, Wang N and Li Y: Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis. Environ Mol Mutagen 50: 361-366, 2009.
39. Yang JH, Wu MY, Chen MJ, Chen SU, Yang YS and Ho HN: Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis. Fertil Steril 91 (5 Suppl): 2193-2198, 2009.
40. Yi KW, Kim SH, Ihm HJ, Oh YS, Chae HD, Kim CH and Kang BM: Increased expression of p21-activated kinase 4 in adenomyosis and its regulation of matrix metalloproteinase-2 and -9 in endometrial cells. Fertil Steril 103: 1089-1097.e2, 2015.
41. Weigel MT, Krämer J, Schem C, Wenners A, Alkatout I, Jonat W, Maass N and Mundhenke C: Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol 160: 74-78, 2012.